More about

Leukemia

News
December 21, 2023
1 min watch
Save

VIDEO: IDH inhibitor treatment sequence for AML a 'hot topic of discussion' at ASH

VIDEO: IDH inhibitor treatment sequence for AML a 'hot topic of discussion' at ASH

In this video, Akriti Jain, MD, discusses whether patients with acute myeloid leukemia with IDH mutations should be treated with IDH inhibitors up front compared to venetoclaxcontaining regimens.

News
December 12, 2023
2 min read
Save

Revumenib represents a ‘significant breakthrough’ for treatment of acute leukemia

Revumenib represents a ‘significant breakthrough’ for treatment of acute leukemia

Revumenib proved safe and effective among pediatric and adult patients with relapsed or refractory KMT2Ar acute myeloid leukemia and acute lymphoid leukemia, according to study results presented at ASH Annual Meeting and Exhibition.

News
December 11, 2023
2 min read
Save

‘Multi-pronged approach’ needed to increase diversity in clinical trials

‘Multi-pronged approach’ needed to increase diversity in clinical trials

In a special scientific session on race and science at ASH Annual Meeting an Exposition, Saad Z. Usmani, MD, MBA, FACP, FRCP, examined clinical trial inclusion from an investigator’s perspective.

News
December 11, 2023
2 min read
Save

Study yields 'encouraging' preliminary data for navitoclax combination in myelofibrosis

Study yields 'encouraging' preliminary data for navitoclax combination in myelofibrosis

SAN DIEGO — Navitoclax added to ruxolitinib led to a significant improvement in spleen volume reduction compared with placebo among patients with untreated myelofibrosis, study results presented at ASH Annual Meeting and Exposition showed.

News
December 10, 2023
2 min read
Save

Study suggests ‘significant’ link between sickle cell trait, leukemia

Study suggests ‘significant’ link between sickle cell trait, leukemia

SAN DIEGO — Individuals with sickle cell trait are at increased risk for leukemia, specifically myeloid and monocytic leukemias, according to data presented at ASH Annual Meeting and Exposition.

News
December 10, 2023
3 min read
Save

Oral regimen provides curative, chemotherapy-free treatment of acute promyelocytic leukemia

Oral regimen provides curative, chemotherapy-free treatment of acute promyelocytic leukemia

SAN DIEGO — Oral arsenic trioxide proved safe and effective when used as part of a regimen for treatment of acute promyelocytic leukemia, study results presented at ASH Annual Meeting and Exhibition showed.

News
December 09, 2023
3 min read
Save

AI tool addresses ‘clinical conundrum’ by accurately identifying rare blood cancers

AI tool addresses &lsquo;clinical conundrum&rsquo; by accurately identifying rare blood<b> </b>cancers

SAN DIEGO — An international group of researchers developed an artificial intelligence-based algorithm that differentiates prefibrotic primary myelofibrosis from essential thrombocythemia during pathological analysis, study findings showed.

News
December 09, 2023
3 min read
Save

Using pharmacogenomics to guide induction may reduce racial disparities in pediatric AML

Using pharmacogenomics to guide induction may reduce racial disparities in pediatric AML

Outcomes among children with acute myeloid leukemia treated with high-dose cytarabine-based regimens did not vary by race, according to study results presented at ASH Annual Meeting and Exposition.

News
December 04, 2023
2 min read
Save

FDA approves Jaypirca for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves Jaypirca for chronic lymphocytic leukemia, small lymphocytic lymphoma

The FDA granted accelerated approval to pirtobrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.

News
November 21, 2023
4 min read
Save

Q&A: Supportive care in young adults with leukemia

Q&amp;A: Supportive care in young adults with leukemia

Healio spoke with Nikki Yuill, LCSW, and Michelle Rajotte, LMSW, the director and associate director of The Leukemia & Lymphoma Society’s Information Resource Center, about the importance of supportive care in young adults with leukemia.

View more